Public Opposition Overwhelms Review Panel
The National Capital Planning Commission (NCPC) has delayed its decision on President Donald Trump's controversial $400 million White House ballroom project. The vote, initially scheduled for Thursday, has been moved to April 2, citing an overwhelming volume of public commentary.

The commission revealed it received over 35,000 public comments, with the vast majority expressing strong opposition to the plan. This influx of public sentiment, described as "significant public input" by the NCPC chair, led to the postponement. The proposed ballroom, slated for a 90,000 square foot space where the White House East Wing once stood, has drawn sharp criticism.

A Swathe of Negative Feedback
Public forums saw a stark imbalance, with only one out of 28 speakers at the March meeting voicing support for the project. Many commenters described the ballroom as "gaudy and cheap," a "soulless hotel conference space," and a "gold plated monstrosity." Architects, historians, preservationists, and former White House staff were among those who registered their disapproval, criticizing the scale and perceived lack of necessity for the construction.
Read More: Pentagon AI Head Gavin Kliger Appointed Amid Online Past Concerns

The demolition of the East Wing, which commenced in October, had previously been argued by White House officials as not requiring commission approval. However, officials stated plans for subsequent construction would be presented to the relevant bodies. This sequence of events has fueled public unease and astonishment regarding the project's trajectory.

Political Appointments and Previous Approvals
The postponement occurs amidst concerns about Trump's appointments of allies to the NCPC commission. Separately, the Commission of Fine Arts, which also reviewed the ballroom plans and where Trump has likewise installed loyalists, had previously voted to approve the project.
Despite the public outcry and the NCPC's delay, the Trump administration secured a temporary victory last week when a lawsuit aiming to halt construction was rejected. This suggests the project's path, while currently encountering procedural hurdles, may continue to advance.
Read More: FDA Vaccine Head Dr. Vinay Prasad Leaves Agency End of April 2026